logo

Iovance Biotherapeutics Inc (IOVA) Stock: A Year of Market Fluctuations

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Iovance Biotherapeutics Inc’s current trading price is -76.58% away from its 52-week high, while its distance from the 52-week low is 6.14%. The stock’s price range for this period has been between $3.42 and $15.50 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 6.7 million for the day, a number notably lower than the average daily volume of 9.49 million over the last three months.

Iovance Biotherapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $15.50 on 03/25/24 and a low of $3.42 for the same time frame on 03/21/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly decline of -50.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.19B and boasts a workforce of 838 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.97, with a change in price of -7.04. Similarly, Iovance Biotherapeutics Inc recorded 8,594,024 in trading volume during the last 100 days, posting a change of -65.98%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.06.

IOVA Stock Stochastic Average

As of today, Iovance Biotherapeutics Inc’s raw stochastic average for the last 50 days stands at 5.83%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 9.46%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 5.55% and 3.97%, respectively.

IOVA Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -50.95%. However, over the last six months, the performance has been stronger by -64.93%. The price of IOVA decreased -37.20% over the last 30 days. And in the last five days, it has fallen by -2.94%.

Most Popular